Scientific article
Review
OA Policy
English

Modulation of STAT6 signaling for hepatoprotection

Published inFrontiers in pharmacology, vol. 16, 1659227
Publication date2025
First online date2025-12-02
Abstract

Signal transducer and activator of transcription (STAT) proteins are a family of seven transcription factors mediating various biological processes. STAT6 is classically known to regulate immune cell biology by transmitting signals from interleukin (IL)-4 and IL-13 into transcriptional activation of genes driving type 2 immunity. In orchestrating T helper lymphocytes and macrophages polarization, STAT6 plays a central role in the regulation of both cellular and humoral immunities. Several pathologies, including inflammatory disorders, autoimmune/allergic diseases, metabolic syndrome as well as cancer, are associated with a dysregulation of type 2 immunity related to inadequate expression and/or activity of STAT6. In the present review, following a brief introduction of STAT6 biology, we summarize the immunologic and physiological roles of STAT6 in the context of liver integrity as well as the potential roles of STAT6-mediated pathways in both hepatoprotection and liver pathophysiological mechanisms.

Keywords
  • HCC
  • Ischemia-reperfusion
  • MASH
  • MASLD
  • STAT6
  • Acute liver damage
  • Fibrosis
  • Immune polarization
Citation (ISO format)
SOMM, Emmanuel et al. Modulation of STAT6 signaling for hepatoprotection. In: Frontiers in pharmacology, 2025, vol. 16, p. 1659227. doi: 10.3389/fphar.2025.1659227
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1663-9812
7views
90downloads

Technical informations

Creation10/03/2026 09:15:43
First validation18/03/2026 09:01:56
Update18/03/2026 09:01:56
Status update18/03/2026 09:01:56
Last indexation18/03/2026 09:01:57
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack